Dynatronics (DYNTQ) AI Stock Analysis

Dynatronics

(Other OTC:DYNTQ)

Select Model

Rating:40Underperform

Price Target:$0.01▼(-9.09% Downside)

Action:reiterated

Date:01/28/26

The score is driven primarily by weak financial performance (declining revenue, ongoing losses, high leverage, and strained cash flow). Technical indicators reinforce the risk with a pronounced downtrend and very weak momentum. Valuation does not offset these concerns because the negative P/E is not informative and there is no dividend yield support.

Positive Factors

Recurring consumables and installed-base revenueRepeat-purchase consumables and accessories create a durable revenue stream tied to the installed base rather than one-off capital sales. This aftermarket revenue promotes customer stickiness, predictable recurring receipts and margin support over multiple quarters, softening volatility from episodic equipment orders.

Negative Factors

Declining revenue and shrinking marginsSustained revenue decline and contracting gross, EBIT and net margins reduce operating leverage and limit the firm's ability to fund R&D, sales, or service investments. Persistent top-line and margin deterioration undermines long-term competitiveness and makes recovery harder without structural change or cost restructuring.

Dynatronics (DYNTQ) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $1,605
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): 0.0
Beta (1Y): -2.29
Revenue Growth: ―
EPS Growth: ―
Country: US
Employees: 88
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Specialties

Dynatronics Business Overview & Revenue Model

Company Description

Dynatronics Corporation operates as a medical device enterprise, specializing in the development, manufacturing, and distribution of a wide array of products geared towards physical therapy, rehabilitation, orthopedics, pain management, and athletic...

How the Company Makes Money

Dynatronics makes money primarily by selling rehabilitation and physical therapy equipment and related accessories to healthcare providers and distributors. Key revenue streams have historically included: (1) sales of capital equipment (e.g., electro...

Dynatronics Earnings Call Summary

Earnings Call Date:May 08, 2024(Q3-2024)|% Change Since:-97.70%|Next Earnings Date:―

Earnings Call SentimentNeutral

The earnings call highlighted successful cost reduction efforts and new product launches, which contributed to a decrease in net loss. However, the company faced challenges with decreased net sales and uncertainty regarding new product revenue. The lowered revenue guidance reflects ongoing challenges in demand and customer relationships.

Positive Updates

Cost Reduction and Profitability Improvement

Operating expenses reduced by $3.7 million year-to-date, maintaining gross margin rates year-over-year.

Negative Updates

Decline in Net Sales

Net sales decreased from $9.2 million in Q3 FY 2023 to $7.7 million in Q3 FY 2024 due to changes in private label relationships and decreased demand in orthopedic soft bracing.

Company Guidance

In the third quarter earnings call for fiscal year 2024, Dynatronics provided guidance indicating that net revenues are projected to range between $32.5 million and $34 million due to slower demand in the rehabilitation sector and changes in private label customer relationships. The company did not provide gross margin guidance, citing a need for improved business stabilization before considering reintroducing such forecasts. Selling, general, and administrative expenses (SG&A) are anticipated to be between 30% and 32% of net sales for the fiscal year. The company's focus remains on strengthening customer relationships and enhancing operating profitability and financial flexibility.

Dynatronics Financial Statement Overview

Summary

Financial statements indicate material weakness: declining revenue (TTM growth -2.11%), negative profitability (negative net and EBIT margins), high leverage (debt-to-equity 2.26), and weak cash generation with negative free cash flow growth and liquidity pressure.

Income Statement

35Negative

Balance Sheet

40Negative

Cash Flow

30Negative

Financial statement breakdown
Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	26.81M	27.39M	32.53M	40.61M	44.34M	47.80M
Gross Profit	5.76M	6.01M	7.63M	10.15M	10.67M	12.89M
EBITDA	-9.31M	-9.37M	-976.01K	-3.51M	-2.42M	3.81M
Net Income	-10.74M	-10.90M	-2.70M	-5.66M	-4.73M	1.21M
Balance Sheet
Total Assets	15.00M	15.44M	25.94M	30.06M	35.43M	39.14M
Cash, Cash Equivalents and Short-Term Investments	761.75K	326.34K	483.92K	398.80K	550.11K	6.10M
Total Debt	6.90M	6.63M	6.69M	5.65M	3.84M	5.08M
Total Liabilities	11.94M	12.18M	11.78M	13.21M	13.73M	13.63M
Stockholders Equity	3.06M	3.26M	14.16M	16.86M	21.70M	25.51M
Cash Flow
Free Cash Flow	75.88K	270.13K	-1.85M	185.15K	-5.20M	236.13K
Operating Cash Flow	106.62K	300.58K	-1.61M	372.00K	-4.88M	383.00K
Investing Cash Flow	-30.74K	-30.45K	-243.29K	-187.00K	-319.00K	1.53M
Financing Cash Flow	407.43K	-427.71K	1.84M	-332.71K	-350.00K	2.02M

Dynatronics Technical Analysis

Technical Analysis SentimentNeutral

Last Price0.01

Price Trends

50DMA0.01Negative

100DMA0.03Negative

Market Momentum

MACD-0.00Negative

RSI27.34Positive

STOCH0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DYNTQ, the sentiment is Neutral. The current price of 0.01 is above the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 27.34 is Positive, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DYNTQ.

Dynatronics Risk Analysis

Dynatronics disclosed 36 risk factors in its most recent earnings report. Dynatronics reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Dynatronics Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DYNTQ against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
BJDX	44Neutral	$2.49M	-0.05	-125.01%	―	―	93.91%
DHAI	40Underperform	$209	0.00	24.90%	―	―	―
NUWE	40Underperform	$3.07M	-0.00	-605.75%	―	8.36%	88.88%
DYNTQ	40Underperform	$1,605	0.00	-283.52%	―	―	―

* Healthcare Sector Average

Performance Comparison

DYNTQ and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DYNTQ	Dynatronics Corporation	0.01	-0.03	-75.56%
NUWE	Nuwellis, Inc.	5.68	-866.37	-99.35%
BBLG	Bone Biologics Corp	0.38	-1.66	-81.37%
BJDX	Bluejay Diagnostics, Inc.	0.56	-6.56	-92.19%
DHAI	DIH Holdings US, Inc Class A	0.02	-1.79	-98.90%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jan 27, 2026

Dynatronics AI Stock Analysis